This inventor holds 1 USPTO granted patent. Top assignees: Emory University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Company Filing History:
1 out of 1,024 
1 out of 3,693 
Years Active: 2014
Title: Manl Cheruvu: Innovator in Vaccine Development
Introduction
Manl Cheruvu is a notable inventor based in Savannah, GA (US). He has made significant contributions to the field of immunology, particularly in vaccine development. His innovative work focuses on creating effective strategies to combat infectious diseases.
Latest Patents
Cheruvu holds a patent for a polypeptide vaccine and vaccination strategy against Mycobacterium. This vaccine is designed to elicit an immune response by administering a polypeptide or a combination of peptides to a subject. The polypeptide vaccine is utilized as part of a prime-boost strategy alongside the BCG vaccine, enhancing immunoprotection in subjects to achieve disease prevention or elimination. Additionally, a pharmaceutical package is provided that encompasses this polypeptide vaccine, ensuring effective immunoprotection upon administration.
Career Highlights
Throughout his career, Manl Cheruvu has worked with prestigious institutions such as Emory University and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these organizations has allowed him to collaborate with leading experts in the field of health and medicine.
Collaborations
Some of his notable coworkers include Suraj Sable and Bonnie B Plikaytis, who have contributed to his research endeavors.
Conclusion
Manl Cheruvu's innovative work in vaccine development highlights his commitment to advancing public health through scientific research. His contributions are vital in the ongoing fight against infectious diseases, showcasing the importance of innovation in medicine.